Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pLKO-PTEN-shRNA-1320 Citations (8)

Originally described in: Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA.
Kim JS, Lee C, Bonifant CL, Ressom H, Waldman T Mol Cell Biol. 2007 Jan . 27(2):662-77.
PubMed Journal

Articles Citing pLKO-PTEN-shRNA-1320

mTOR inhibitors radiosensitize PTEN-deficient non-small-cell lung cancer cells harboring an EGFR activating mutation by inducing autophagy. Kim EJ, Jeong JH, Bae S, Kang S, Kim CH, Lim YB. J Cell Biochem. 2013 Jun;114(6):1248-56. doi: 10.1002/jcb.24465. PubMed
Sestrin2 protein positively regulates AKT enzyme signaling and survival in human squamous cell carcinoma and melanoma cells. Zhao B, Shah P, Budanov AV, Qiang L, Ming M, Aplin A, Sims DM, He YY. J Biol Chem. 2014 Dec 26;289(52):35806-14. doi: 10.1074/jbc.M114.595397. Epub 2014 Nov 6. PubMed
MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN. Chen J, Yan D, Wu W, Zhu J, Ye W, Shu Q. Oncol Rep. 2016 Jun;35(6):3285-92. doi: 10.3892/or.2016.4719. Epub 2016 Mar 31. PubMed
MicroRNA-92a promotes metastasis of nasopharyngeal carcinoma by targeting the PTEN/AKT pathway. Zhang H, Cao H, Xu D, Zhu K. Onco Targets Ther. 2016 Jun 16;9:3579-88. doi: 10.2147/OTT.S105470. eCollection 2016. PubMed
Distinct Role of Sesn2 in Response to UVB-Induced DNA Damage and UVA-Induced Oxidative Stress in Melanocytes. Zhao B, Shah P, Qiang L, He TC, Budanov A, He YY. Photochem Photobiol. 2016 Jul 27. doi: 10.1111/php.12624. PubMed
Differential regulation of the pro-inflammatory biomarker, YKL-40/CHI3L1, by PTEN/Phosphoinositide 3-kinase and JAK2/STAT3 pathways in glioblastoma. Wang Y, Wong CW, Yan M, Li L, Liu T, Or PM, Tsui SK, Waye MM, Chan AM. Cancer Lett. 2018 Aug 10;429:54-65. doi: 10.1016/j.canlet.2018.04.040. Epub 2018 May 3. PubMed
INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors. Li Q, Jiang B, Guo J, Shao H, Del Priore IS, Chang Q, Kudo R, Li Z, Razavi P, Liu B, Boghossian AS, Rees MG, Ronan MM, Roth JA, Donovan KA, Palafox M, Reis-Filho JS, de Stanchina E, Fischer ES, Rosen N, Serra V, Koff A, Chodera JD, Gray NS, Chandarlapaty S. Cancer Discov. 2022 Feb;12(2):356-371. doi: 10.1158/2159-8290.CD-20-1726. Epub 2021 Sep 20. PubMed
Down-regulation of miR-424 inhibited the metastasis of endometrial carcinoma via targeting PTEN/PI3K/AKT signaling pathway. Lu Y, Lin Q, Lin C, Chen J, Jiang X, He H. J Cancer. 2023 Sep 4;14(15):2811-2819. doi: 10.7150/jca.87021. eCollection 2023. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.